Caricamento...
4CPS-150 Use of adalimumab for hidradenitis suppurativa
BACKGROUND: Adalimumab is an antibody against tumour necrosis factor-α currently indicated for moderate to severe hidradenitis suppurative (HS). PURPOSE: To assess the effectiveness and safety of adalimumab in patients with HS. MATERIAL AND METHODS: A retrospective study of patients with HS and trea...
Salvato in:
| Pubblicato in: | Eur J Hosp Pharm |
|---|---|
| Autori principali: | , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMJ Group
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535183/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.241 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|